ATOS MEDICAL UK LIMITED
Get an alert when ATOS MEDICAL UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£13M
+55.7% highest in 4 filed years
Employees
112
+9.8% highest in 4 filed years
Profit before tax
£6.3M
+36.9% highest in 4 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
We draw attention to note 2.3 in the financial statements, which indicates that on 1 June 2026, all of the trade and assets of Atos Medical UK Limited will be transferred as a going concern to Coloplast Limited. The company will cease trading on 1 June 2026. Our opinion is not modified in respect of this matter.
-
Going-concern uncertainty disclosed
Net assets
4-year trend · vs Consumer Discretionary median
Accounts
4-year trend · Δ = latest vs prior filed period · latest reflected 2025-09-30
| Metric | Trend | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | Δ vs prior |
|---|---|---|---|---|---|---|
| Turnover | £17,894,000 | £29,803,000 | £31,990,000 | £34,639,000 | +8.3% | |
| Operating profit | £960,000 | £3,818,000 | £4,517,000 | £6,164,000 | +36.5% | |
| Profit before tax | £960,000 | £3,840,000 | £4,632,000 | £6,339,000 | +36.9% | |
| Net profit | £758,000 | £3,006,000 | £3,440,000 | £4,721,000 | +37.2% | |
| Cash | — | — | — | — | — | |
| Total assets less current liabilities | £5,114,000 | £8,074,000 | £8,513,000 | £13,254,000 | +55.7% | |
| Net assets | £5,052,000 | £8,058,000 | £8,512,000 | £13,254,000 | +55.7% | |
| Equity | £5,052,000 | £8,058,000 | £8,512,000 | £13,254,000 | +55.7% | |
| Average employees | 86 | 104 | 102 | 112 | +9.8% | |
| Wages | £2,420,000 | £4,213,000 | £4,243,000 | £4,459,000 | +5.1% | |
| Directors' remuneration | £141,000 | £286,000 | £279,000 | £243,000 | -12.9% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|---|---|
| Operating margin | 5.4% | 12.8% | 14.1% | 17.8% | |
| Net margin | 4.2% | 10.1% | 10.8% | 13.6% | |
| Return on capital employed | 18.8% | 47.3% | 53.1% | 46.5% | |
| Current ratio | — | 3.03x | 3.19x | 4.02x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- ATOS MEDICAL UK LIMITED 2021-03-10 → present
- COUNTRYWIDE SUPPLIES LIMITED 2001-04-26 → 2021-03-10
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Page Kirk LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“We draw attention to note 2.3 in the financial statements, which indicates that on 1 June 2026, all of the trade and assets of Atos Medical UK Limited will be transferred as a going concern to Coloplast Limited. The company will cease trading on 1 June 2026. Our opinion is not modified in respect of this matter.”
Significant events
- “There are currently several economic risks impacting both the World and UK economy. The on-going conflict in both Ukraine and the Middle East remains uncertain and continues to have global impact.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHAPUIS, Pascale | Director | 2022-03-07 | Aug 1970 | French |
| MIKKELSEN, Anton | Director | 2023-09-13 | May 1987 | Danish |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| STOCKLEY, Peter Darran | Secretary | 2001-04-27 | 2015-01-30 |
| WHITE ROSE FORMATIONS LIMITED | Corporate Nominee Secretary | 2001-04-26 | 2001-04-27 |
| BERTHELSEN, Ulrik | Director | 2018-10-29 | 2019-10-28 |
| BJERRE, Claus | Director | 2015-01-30 | 2018-10-29 |
| EICKHOFF, Philip Harald | Director | 2015-01-30 | 2019-08-28 |
| HANSVEDEN, John | Director | 2022-09-16 | 2023-05-03 |
| HUMPHREYS, Jennifer Ann | Director | 2005-05-04 | 2015-01-30 |
| HUMPHREYS, Peter James | Director | 2001-04-26 | 2005-05-04 |
| HUTTON, Stephanie, Finance & Operations Diector | Director | 2018-01-26 | 2018-07-13 |
| KNIGHT, Ashley | Director | 2022-09-15 | 2026-02-12 |
| KNIGHT, Ashley Alexander Julian | Director | 2020-03-25 | 2022-03-07 |
| LEIRE, Mattias | Director | 2015-01-30 | 2016-10-31 |
| MADSEN, Egil Molsted | Director | 2022-03-07 | 2022-09-15 |
| NICHOLL, James | Director | 2001-04-26 | 2005-05-04 |
| NICHOLL, Jennifer Mary | Director | 2005-05-04 | 2015-01-30 |
| RENSHAW, Jamie | Director | 2018-07-09 | 2022-03-07 |
| SKAK OLUFSEN, Christian | Director | 2022-03-07 | 2023-05-09 |
| STOCKLEY, Peter Darran | Director | 2001-04-26 | 2015-01-30 |
| VAN-AS BROOKS, Corina | Director | 2017-08-13 | 2020-03-31 |
| WALKER, Alastair James | Director | 2016-09-23 | 2018-01-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Niels Peter Louis-Hansen | Individual | Shares 25–50%, Voting 50–75%, Appoints directors | 2023-09-01 | Active |
| Atos Medical Ab | Corporate entity | Shares 75–100% | 2018-10-29 | Ceased 2018-10-29 |
| Atos Medical Ab | Corporate entity | Shares 75–100% | 2018-10-29 | Ceased 2018-10-29 |
| Atos Medical Ab | Corporate entity | Shares 75–100% | 2016-04-06 | Ceased 2018-10-29 |
Filing timeline
Last 20 of 124 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-19 | AA | accounts | Accounts with accounts type full | |
| 2026-05-15 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-04-30 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-04-30 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2026-04-30 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2026-04-30 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-04-30 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-03-05 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-02 | AA | accounts | Accounts with accounts type full | |
| 2025-05-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-17 | AA | accounts | Accounts with accounts type full | |
| 2024-05-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-09 | AA | accounts | Accounts with accounts type full | |
| 2023-09-13 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-09 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-03 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-29 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-15 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-15 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.